g 25671 has been researched along with sulfinpyrazone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cerletti, C; de gaetano, G; del Maschio, A; Hatmi, M; Lefort, J; Vargaftig, BB | 1 |
| Eller, BT; Lucchesi, BR; Lynch, JJ; Patterson, E | 1 |
| Cerletti, C; De Gaetano, G; Del Maschio, A; Livio, M | 1 |
| Lewis, GP; Smith, JR | 1 |
| CURRIE, JP; WILHELMI, G | 1 |
| BRODIE, BB; BURNS, JJ; GUTMAN, AB; PEREL, JM; RITTERBAND, A; YU, TF | 1 |
| Halder, P; Mhaske, SB | 1 |
7 other study(ies) available for g 25671 and sulfinpyrazone
| Article | Year |
|---|---|
Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bronchi; Humans; Lung; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Sulfinpyrazone | 1987 |
Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite G25671.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Cyclooxygenase Inhibitors; Dogs; Electrophysiology; Male; Myocardial Infarction; Sulfinpyrazone; Ventricular Fibrillation | 1987 |
Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Kinetics; Malondialdehyde; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Sulfinpyrazone; Thromboxane B2 | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
[Pharmacological and clinical characteristics of G 25671 (Geigy Basel), a new preparation of the pyrazolidine series].
Topics: Analgesics; Humans; Sulfinpyrazone | 1954 |
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.
Topics: Analgesics; Phenylbutazone; Safrole; Sulfinpyrazone; Sulfoxides; Uric Acid; Uricosuric Agents | 1957 |
PIDA-mediated N-N bond formation to access pyrazolidine-3,5-diones: a novel process for uricosuric agents G-25671 and sulfinpyrazone.
Topics: Oxidation-Reduction; Sulfinpyrazone; Uricosuric Agents | 2023 |